Skip to content
Recall Observatory FDA recall evidence

Drug product

Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-496-30

D-0095-2024

October 20, 2023

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 93219
Status
Ongoing
Classification
Class II
Quantity
5,856 bottles
Official record key
drug-enforcement:D-0095-2024

Official wording

Reason: Failed Dissolution Specifications

Code information: Lot #: 17220063, Exp 12/2023; 17220396, 17220397, Exp 01/2024; 17220965, Exp 04/2024; 17221187, 17221523, Exp 07/2024; 17221793, 17221794, 17221801, Exp 08/2024

Distribution pattern: USA nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications